How It Works
Sermorelin is a synthetic peptide consisting of the first 29 amino acids of human growth hormone-releasing hormone (GHRH 1-29). This represents the shortest fully functional fragment of GHRH that retains complete biological activity. It was developed and previously FDA approved under the brand name Geref for diagnostic testing and treatment of GH deficiency in children, though approval was later withdrawn for commercial (not safety) reasons.
Sermorelin works by binding to GHRH receptors on somatotroph cells in the anterior pituitary gland, stimulating the natural synthesis and pulsatile release of endogenous growth hormone. This mechanism preserves the body's normal feedback regulation through the GH/IGF-1 axis, somatostatin inhibition, and the natural circadian rhythm of GH secretion — a critical advantage over direct exogenous GH administration.
When injected at bedtime, Sermorelin amplifies the nocturnal GH pulse — the largest natural GH release of the day. Over time, this leads to improved body composition, enhanced recovery, better sleep quality, and various anti-aging benefits associated with optimized GH levels.
Benefits
- Stimulates natural, pulsatile GH release — preserves physiological regulation
- Improved body composition — increased lean mass and reduced body fat over 3-6 months
- Enhanced sleep quality — deeper sleep through amplified nocturnal GH pulse
- Anti-aging effects — improved skin elasticity, energy, and vitality
- Good safety profile — decades of clinical use and research
- May restore pituitary sensitivity — potentially improving endogenous GH secretion long-term
Side Effects
- Injection site reactions — redness, swelling, pain (most common)
- Facial flushing — warmth immediately after injection, usually transient
- Headache — occasional, typically resolves with continued use
- Dizziness — rare
- Difficulty swallowing — rare, reported in some clinical trials
- Joint stiffness — typically mild, related to GH-mediated effects
- Generally well-tolerated with a favorable safety profile over long treatment periods
Dosing Protocol
| Parameter | Details |
|---|---|
| Standard Dose | 200-500mcg per injection |
| Frequency | Once nightly, 30-60 minutes before bedtime |
| Administration | Subcutaneous injection (abdomen or thigh) |
| Cycle Length | 3-6 months continuously |
| Fasting | Empty stomach — no food for 2+ hours before injection |
| Monitoring | Check IGF-1 levels at baseline and every 3 months |
What You Will Need
- Sermorelin lyophilized vial (typically 9mg or 15mg)
- Bacteriostatic water (30mL)
- Insulin syringes (1mL, 29-31ga)
- Alcohol swabs
- Sharps container